Anti-Snoring Devices Market is segmented By Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, Others), By Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
市場規模(米ドル) Bn
CAGR7.1%
調査期間 | 2024 - 2031 |
推定基準年 | 2023 |
CAGR | 7.1% |
市場の集中度 | High |
主要プレイヤー | ResMed, Koninklijke Philips NV, SomnoMed, Fisher & Paykel Healthcare Limited, GSK plc. and Among Others. |
The anti-snoring devices market is estimated to be valued at USD 1.6 Bn in 2024 and is expected to reach USD 2.58 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031. Consistent with the growing prevalence of sleep disorders and increasing awareness about treatment options, demand for anti-snoring devices is expected to increase steadily over the forecast period.
The market is driven by the rising number of people suffering from sleep apnea and snoring issues. Advancements in technologies used in anti-snoring devices are further fueling the demand. Mandibular advancement devices are gaining popularity due to their effectiveness and relatively lower cost compared to other anti-snoring devices like tongue stabilizing devices and nasal devices.